Company intelligence / Profile preview

Aurora Portugal

Portugal

Ownership: Private
Development stage: Other

Overview

Aurora Portugal is the Portuguese medical cannabis production company established after Aurora Cannabis acquired a 51% stake in Gaia Pharm Lda and renamed the entity Aurora Portugal Lda. The business was created to cultivate and manufacture pharmaceutical-grade medical cannabis and derivative products in Portugal for supply to Portuguese patients and export into European medical cannabis markets. Aurora Portugal appears to function primarily as a production and regional supply asset within Aurora Cannabis's international network rather than as a standalone drug-development biotech. Its strategic role is tied to EU-compliant cultivation and manufacturing to support Aurora's broader medical cannabis portfolio in Europe.

Therapeutic areas: OncologyNeurologyOther
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Aurora Portugal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aurora Portugal.

Explore the full profile